RankAlpha logo
Back to Rankings

LENZ

LENZ TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
LENZ vs peer average
36/100
LENZ vs. peer average (D vs. C)
Grade spread
A 2 · B 2 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

DSGN is the first available peer comparator.

Design Therapeutics: comparable market-cap biotech with late-stage development programs and focus on specialty indications; peer for funding/enrollment dynamics.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerDSGNDesign Therapeutics
LENZ
LENZ Therapeutics
DSGN
Design Therapeutics
Grade
D
C
Momentum
2
34
Value
41
41
Sentiment
100
81
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs DSGN

LENZ / DSGN
Grade Position
Below peers
LENZ vs. peer average (D vs. C)
36/100
Momentum
2
DSGN
Value
41
LENZ
Sentiment
100
LENZ

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LENZ
1
DSGN
DSGN
C
60/100
-1
2
AUTL
AUTL
B
80/100
-2
3
IKT
Inhibikase Therapeutics Inc Common
B
80/100
-2
4
CNTX
Context Therapeutics Inc Common
A
100/100
-3
5
NERV
Minerva Neurosciences Inc Common
A
100/100
-3
DSGN is the first peer returned for this comparison set.